Qualitative and psychometric evaluation of the PROMIS®-Fatigue SF-7a scale to assess fatigue in patients with moderately to severely active inflammatory bowel disease

Journal of Patient-Reported Outcomes

Table 3 Patient and disease demographics at baseline in GALAXI (CD patients) and VEGA (UC patients)

CD and UC patients were derived from pooled treatment groups from GALAXI and VEGA studies, respectively. Data are being reported as mean (SD), unless otherwise specified. CD, Crohn’s disease; CDAI, Crohn’s Disease Activity Index; IBDQ, Inflammatory Bowel Disease Questionnaire; PROMIS, Patient-Reported Outcomes Measurement Information System; SD, standard deviation; SF-7a, Short Form-7a; UC, ulcerative colitis. ^aBased on 353 CD patients. ^bBased on 209 UC patients